Support & Solvents
Injection Kit
50 syringes + 100 padsEverything required to safely reconstitute and inject reconstituted peptides — 50 sterile insulin syringes plus 100 alcohol prep pads.
$25
Tetrasubstituted GHRH(1-29) analog · Short pulsatile half-life · 30-AA
Tetrasubstituted GHRH(1-29) analog — Mod GRF 1-29, the foundational GHRH peptide for short-pulse protocols.
Per-lot analytical report — HPLC, ESI-MS, LAL endotoxin, heavy metals, sterility
Buy CJC-1295 No DAC 5mg at IGF1 Shop. CJC-1295 No DAC, also known as Modified GRF 1-29, is a 30-amino-acid analog of native growth hormone-releasing hormone with four amino acid substitutions that confer resistance to enzymatic degradation while preserving full GHRH receptor activity. Without the DAC linker, its half-life remains short (~30 minutes) — making CJC-1295 No DAC the standard pick for pulsatile GH release protocols and the canonical partner for Ipamorelin stacking. Every CJC-1295 No DAC 5mg vial is HPLC-verified at ≥99% purity, mass-spec confirmed, and accompanied by a per-lot Certificate of Analysis.
Also known as: CJC-1295 No DAC · Modified GRF 1-29 · Mod GRF 1-29 · CJC 1295 No DAC
CJC-1295 No DAC (Mod GRF 1-29) is a 30-amino-acid synthetic analog of native growth hormone-releasing hormone. Four amino acid substitutions confer resistance to enzymatic degradation while preserving full GHRH receptor activity. Without DAC conjugation, half-life remains short (~30 min) — ideal for pulsatile GH release.
Every lot of CJC-1295 (No DAC) is released only after passing reverse-phase HPLC (≥ 99% area purity at 220 nm against a reference standard), ESI mass spectrometry confirmation of molecular weight, and Limulus Amebocyte Lysate (LAL) endotoxin testing below 0.5 EU/mg. The lot-specific Certificate of Analysis is provided with the order and available on request before purchase.